60¢sixtycents

Neuphoria Therapeutics Inc.NEUP

$4.31+0.00 (+0.00%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$23M
Micro-cap
-100%
2021 — today
10-Year Price
-97%
2021 — today
52-Week Range
$3.72$20.00
Current $4.31· 4%

Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.

Valuation in context

P/E ratio
-0.4
N/A
Not meaningful — company is unprofitable
P/B ratio
0.8
Historically cheap
Historically cheap relative to the last 10 years
FCF Yield
255.0%
Historically high
Historically high relative to the last 10 years
Free · No credit card needed

Get alerted when NEUP is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.